An indirect wholly-owned subsidiary of CHAOJU EYE CARE (02219) has made a significant investment in a financial product.
On July 23, 2026, Chaoju Eye Care Medical (Hong Kong) Company Limited, known as Chaoju Hong Kong, subscribed for a structured deposit product with a total principal amount of US$16 million. The product is provided by JPMorgan Chase Bank.
The funding for this subscription was sourced from the group's surplus cash reserves and was not derived from the proceeds of its global offering.